BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 15627212)

  • 41. The generation of immunocompetent dendritic cells from CD34+ acute myeloid or lymphoid leukemia cells.
    Tsuchiya T; Hagihara M; Shimakura Y; Ueda Y; Gansuvd B; Munkhbat B; Inoue H; Tazume K; Kato S; Hotta T
    Int J Hematol; 2002 Jan; 75(1):55-62. PubMed ID: 11843292
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Acute myelogenous leukemia blasts as accessory cells during in vitro T lymphocyte activation.
    Bruserud O; Ulvestad E
    Cell Immunol; 2000 Nov; 206(1):36-50. PubMed ID: 11161436
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterization of several leukemia-associated antigens inducing humoral immune responses in acute and chronic myeloid leukemia.
    Greiner J; Ringhoffer M; Taniguchi M; Hauser T; Schmitt A; Döhner H; Schmitt M
    Int J Cancer; 2003 Aug; 106(2):224-31. PubMed ID: 12800198
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [In vitro stimulation of specific antileukemia T-cell response by dendritic cells derived from CD14+ acute monocytic leukemia cells].
    Sheng LX; Xie XB; Qiu GQ; Gu WY; Wang ZL; Wu HQ
    Ai Zheng; 2005 Nov; 24(11):1338-44. PubMed ID: 16552959
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interleukin-12 production by leukemia-derived dendritic cells counteracts the inhibitory effect of leukemic microenvironment on T cells.
    Curti A; Pandolfi S; Aluigi M; Isidori A; Alessandrini I; Chiodoni C; Testoni N; Colombo MP; Baccarani M; Lemoli RM
    Exp Hematol; 2005 Dec; 33(12):1521-30. PubMed ID: 16338495
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Induction of leukemia-specific cytotoxic response by cross-presentation of late-apoptotic leukemic blasts by autologous dendritic cells of nonleukemic origin.
    Spisek R; Chevallier P; Morineau N; Milpied N; Avet-Loiseau H; Harousseau JL; Meflah K; Gregoire M
    Cancer Res; 2002 May; 62(10):2861-8. PubMed ID: 12019165
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Acute lymphoblastic leukemia-derived dendritic cells express tumor associated antigens: PNPT1, PMPCB, RHAMM, BSG and ERCC1.
    Luczynski W; Kowalczuk O; Stasiak-Barmuta A; Ilendo E; Krawczuk-Rybak M; Chyczewski L
    Neoplasma; 2009; 56(5):428-34. PubMed ID: 19580345
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Costimulatory function of umbilical cord blood CD14+ and CD34+ derived dendritic cells.
    Dilioglou S; Cruse JM; Lewis RE
    Exp Mol Pathol; 2003 Aug; 75(1):18-33. PubMed ID: 12834622
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Generation of multi-leukemia antigen-specific T cells to enhance the graft-versus-leukemia effect after allogeneic stem cell transplant.
    Weber G; Gerdemann U; Caruana I; Savoldo B; Hensel NF; Rabin KR; Shpall EJ; Melenhorst JJ; Leen AM; Barrett AJ; Bollard CM
    Leukemia; 2013 Jul; 27(7):1538-47. PubMed ID: 23528871
    [TBL] [Abstract][Full Text] [Related]  

  • 50. PRAME expression is not associated with down-regulation of retinoic acid signaling in primary acute myeloid leukemia.
    Steinbach D; Pfaffendorf N; Wittig S; Gruhn B
    Cancer Genet Cytogenet; 2007 Aug; 177(1):51-4. PubMed ID: 17693191
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Defective killing of dendritic cells by autologous natural killer cells from acute myeloid leukemia patients.
    Fauriat C; Moretta A; Olive D; Costello RT
    Blood; 2005 Sep; 106(6):2186-8. PubMed ID: 15928036
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The study of dendritic cells derived from acute myeloid leukemia cells].
    Tong XM; Jin J; Xue YQ; Wang YG
    Zhonghua Nei Ke Za Zhi; 2004 Jan; 43(1):45-8. PubMed ID: 14990022
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Stimulation of autologous proliferative and cytotoxic T-cell responses by "leukemic dendritic cells" derived from blast cells in acute myeloid leukemia.
    Harrison BD; Adams JA; Briggs M; Brereton ML; Yin JA
    Blood; 2001 May; 97(9):2764-71. PubMed ID: 11313269
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CD4(+)and CD8(+)T-cell reactions against leukemia-associated- or minor-histocompatibility-antigens in AML-patients after allogeneic SCT.
    Steger B; Milosevic S; Doessinger G; Reuther S; Liepert A; Braeu M; Schick J; Vogt V; Schuster F; Kroell T; Busch DH; Borkhardt A; Kolb HJ; Tischer J; Buhmann R; Schmetzer H
    Immunobiology; 2014 Apr; 219(4):247-60. PubMed ID: 24315637
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immune responses to RHAMM in patients with acute myeloid leukemia after chemotherapy and allogeneic stem cell transplantation.
    Casalegno-Garduño R; Meier C; Schmitt A; Spitschak A; Hilgendorf I; Rohde S; Hirt C; Freund M; Pützer BM; Schmitt M
    Clin Dev Immunol; 2012; 2012():146463. PubMed ID: 22719778
    [TBL] [Abstract][Full Text] [Related]  

  • 56. FLT3-regulated antigens as targets for leukemia-reactive cytotoxic T lymphocytes.
    Brackertz B; Conrad H; Daniel J; Kast B; Krönig H; Busch DH; Adamski J; Peschel C; Bernhard H
    Blood Cancer J; 2011 Mar; 1(3):e11. PubMed ID: 22829124
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Improved effector function of leukemia-specific T-lymphocyte clones trained with AML-derived dendritic cells.
    Schuster FR; Buhmann R; Reuther S; Hubner B; Grabrucker C; Liepert A; Reibke R; Lichtner P; Yang T; Kroell T; Kolb HJ; Borkhardt A; Schmetzer H
    Cancer Genomics Proteomics; 2008; 5(5):275-86. PubMed ID: 19129558
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differentiation of acute and chronic myeloid leukemic blasts into the dendritic cell lineage: analysis of various differentiation-inducing signals.
    Kharfan-Dabaja M; Ayala E; Lindner I; Cejas PJ; Bahlis NJ; Kolonias D; Carlson LM; Lee KP
    Cancer Immunol Immunother; 2005 Jan; 54(1):25-36. PubMed ID: 15693136
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Abundant expression of fibronectin is a major feature of leukemic dendritic cells differentiated from patients with acute myeloid leukemia.
    Vialle-Castellano A; Gaugler B; Mohty M; Isnardon D; van Baren N; Olive D
    Leukemia; 2004 Mar; 18(3):426-33. PubMed ID: 14737076
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The in vitro generation of multi-tumor antigen-specific cytotoxic T cell clones: Candidates for leukemia adoptive immunotherapy following allogeneic stem cell transplantation.
    Mohamed YS; Bashawri LA; Vatte C; Abu-Rish EY; Cyrus C; Khalaf WS; Browning MJ
    Mol Immunol; 2016 Sep; 77():79-88. PubMed ID: 27490939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.